VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $74.00K, a 54.04% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $70.00K, a 38.05% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $161.00K, a 82.95% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-12-31 was $113.00K, a 2725.00% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2026 was $231.00K, a 14.93% increase from fiscal 2025.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $201.00K, a 2412.50% increase from fiscal 2024.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $8.00K, a 87.30% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $63.00K, a 36.56% decline from fiscal 2022.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $74.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $231.00K 10-K · filed 2026-06-15 | |
| 2025-12-31 | $70.00K 10-Q · filed 2026-02-12 | |
| 2025-06-30 | $161.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $201.00K 10-K · filed 2026-06-15 | |
| 2024-12-31 | $113.00K 10-Q · filed 2026-02-12 | |
| 2024-06-30 | $88.00K 10-Q · filed 2026-02-12 | |
| 2024-03-31 | $8.00K 10-K · filed 2025-06-17 | |
| 2023-12-31 | $4.00K 10-Q · filed 2025-02-13 | |
| 2023-06-30 | $4.00K 10-Q · filed 2025-02-13 | |
| 2023-03-31 | $63.00K 10-K · filed 2024-06-11 | |
| 2022-12-31 | $7.00K 10-Q · filed 2024-02-13 | |
| 2022-06-30 | $56.10K 10-Q · filed 2024-02-13 | |
| 2022-03-31 | $99.30K 10-K · filed 2023-06-28 | |
| 2021-12-31 | $67.80K 10-Q · filed 2023-02-07 | |
| 2021-06-30 | $31.60K 10-Q · filed 2023-02-07 | |
| 2021-03-31 | $26.20K 10-K · filed 2022-06-23 | |
| 2020-12-31 | $13.60K 10-Q · filed 2022-02-10 | |
| 2020-06-30 | $12.60K 10-Q · filed 2022-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |